Clinical Trial Update: Phase I Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Plus GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) Plus Dose Escalation of IL-3 (Interleukin-3) in Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

This Phase I trial assessed a FLAC chemotherapy regimen (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) with GM-CSF and dose-escalated IL-3 in metas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Adriamycin (doxorubicin)
• Cytoxan (cyclophosphamide)
• GM-CSF (Leukine) (granulocyte-macrophage colony-stimulating factor)
• Interleukin-3 (interleukin-3)
• Leucovorin (folinic acid)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Neoplasms, Neoplasm Metastasis | Phase 1 | Status: COMPLETED